Price & volume screen · refreshed after the Nov 11, 2026 close
Six-month momentum leaders: Healthcare
Large companies with the strongest six-month price performance. Ranks companies worth at least $1B by their six-month split-adjusted return.
| # | Company | Price | 1M | 6M | From high | Mkt cap |
|---|---|---|---|---|---|---|
| 151 | SOLVSolventumHealthcare | $89.38 | +3.6% | +20.1% | −3.3% | $15.19B |
| 152 | TFXTeleflex IncorporatedHealthcare | $155.39 | +24.9% | +19.5% | 0.0% | $6.16B |
| 153 | ELVNEnliven TherapeuticsHealthcare | $51.64 | +30.8% | +18.5% | −15.6% | $3.80B |
| 154 | TARSTarsus PharmaceuticalsHealthcare | $76.40 | +7.9% | +18.2% | −15.8% | $3.77B |
| 155 | TEVATeva Pharmaceutical Industries LimitedHealthcare | $42.80 | +3.8% | +18.1% | −0.4% | $49.94B |
| 156 | HCSGHealthcare Services GroupHealthcare | $25.24 | +20.8% | +17.4% | −4.9% | $1.70B |
| 157 | HCAHCA HealthcareHealthcare | $500.31 | +8.6% | +17.0% | −8.2% | $104.51B |
| 158 | TVTXTravere TherapeuticsHealthcare | $51.88 | +0.2% | +16.5% | −23.2% | $4.98B |
| 159 | RMDResMedHealthcare | $235.33 | +0.1% | +16.3% | −14.7% | $33.10B |
| 160 | BBIOBridgeBio PharmaHealthcare | $79.19 | +25.1% | +15.4% | −12.2% | $15.43B |
| 161 | UHSUniversal Health ServicesHealthcare | $195.07 | +9.0% | +14.1% | −20.1% | $11.25B |
| 162 | AGIOAgios PharmaceuticalsHealthcare | $32.67 | +8.1% | +13.6% | −28.2% | $1.95B |
| 163 | PFEPfizerHealthcare | $29.24 | +3.1% | +12.6% | −5.0% | $166.67B |
| 164 | IDYAIDEAYA BiosciencesHealthcare | $32.40 | −5.4% | +12.1% | −23.7% | $3.13B |
| 165 | ENOVEnovisHealthcare | $28.74 | +51.3% | +11.8% | −8.8% | $1.66B |
| 166 | HRMYHarmony Biosciences HoldingsHealthcare | $34.25 | −7.5% | +11.1% | −20.1% | $2.01B |
| 167 | WRBYWarby ParkerHealthcare | $31.63 | +19.3% | +11.0% | 0.0% | $3.93B |
| 168 | BMYBristol-Myers SquibbHealthcare | $62.18 | +9.7% | +10.3% | −8.7% | $127.10B |
| 169 | ZTSZOETISHealthcare | $81.49 | +9.7% | +9.6% | −37.8% | $33.11B |
| 170 | MDLNMedlineHealthcare | $42.05 | +17.8% | +8.6% | −15.9% | $36.95B |
| 171 | CDRECadre HoldingsHealthcare | $33.97 | +29.9% | +8.6% | −26.3% | $1.46B |
| 172 | BMRNBioMarin PharmaceuticalsHealthcare | $57.82 | +6.3% | +8.0% | −17.7% | $11.20B |
| 173 | NVAXNovavaxHealthcare | $9.97 | −22.3% | +8.0% | −22.3% | $1.64B |
| 174 | NBIXNeurocrine BiosciencesHealthcare | $173.94 | +28.7% | +7.8% | −6.2% | $17.61B |
| 175 | NHCNational HealthcareHealthcare | $209.82 | −9.3% | +7.8% | −15.4% | $3.29B |
| 176 | SHCSotera HealthHealthcare | $16.47 | −9.6% | +6.4% | −15.9% | $4.70B |
| 177 | NVSTEnvista Holdings Corporation Common stock, $0.01 par value per shareHealthcare | $25.42 | +12.2% | +6.3% | −16.0% | $4.08B |
| 178 | PRVAPrivia Health GroupHealthcare | $24.04 | +11.0% | +6.2% | −14.4% | $3.07B |
| 179 | COOThe Cooper CompaniesHealthcare | $62.87 | +15.2% | +5.7% | −25.4% | $11.96B |
| 180 | JAZZJazz PharmaceuticalsHealthcare | $245.61 | +16.7% | +5.7% | −6.1% | $15.77B |
| 181 | ALGNAlign TechnologyHealthcare | $170.83 | +19.0% | +5.6% | −13.5% | $12.04B |
| 182 | SYKStrykerHealthcare | $318.46 | +12.7% | +5.4% | −17.8% | $121.23B |
| 183 | LNTHLantheus HoldingsHealthcare | $101.48 | +1.5% | +5.2% | −8.5% | $6.64B |
| 184 | EYENational Vision HoldingsHealthcare | $17.69 | +3.8% | +4.6% | −40.0% | $1.40B |
| 185 | OGNOrganon &Healthcare | $13.87 | +0.7% | +3.9% | −0.2% | $3.64B |
| 186 | ENSGThe Ensign GroupHealthcare | $184.74 | +6.6% | +3.8% | −14.4% | $10.78B |
| 187 | ESTAEstablishment Labs HoldingsHealthcare | $71.57 | +22.4% | +3.6% | −25.2% | $2.13B |
| 188 | DNTHDianthus TherapeuticsHealthcare | $88.53 | +14.1% | +3.2% | −23.7% | $4.99B |
| 189 | PNTGThe Pennant GroupHealthcare | $36.74 | −8.5% | +3.2% | −16.6% | $1.29B |
| 190 | ISRGIntuitive SurgicalHealthcare | $446.15 | +5.7% | +3.2% | −24.7% | $154.65B |
| 191 | TNGXTango TherapeuticsHealthcare | $26.32 | +18.4% | +3.2% | −20.0% | $4.46B |
| 192 | NRIXNurix TherapeuticsHealthcare | $16.64 | −24.8% | +2.8% | −40.1% | $1.82B |
| 193 | UTHRUnited TherapeuticsHealthcare | $595.11 | +9.5% | +2.7% | −2.2% | $25.34B |
| 194 | MSAMine Safety IncorporatedHealthcare | $176.03 | −3.2% | +2.1% | −13.3% | $6.78B |
| 195 | INSMInsmedHealthcare | $119.43 | +23.4% | +1.2% | −43.5% | $26.20B |
| 196 | IRMDiRadimedHealthcare | $86.24 | −3.8% | +1.1% | −18.0% | $1.10B |
| 197 | PRAXPraxis Precision MedicinesHealthcare | $350.08 | +43.9% | +0.9% | −9.4% | $9.79B |
| 198 | IARTIntegra LifeSciencesHealthcare | $14.97 | +8.1% | +0.5% | −24.6% | $1.16B |
| 199 | PODDInsuletHealthcare | $149.32 | +8.1% | +0.3% | −56.9% | $10.36B |
| 200 | PAHCPhibro Animal HealthHealthcare | $35.30 | −4.1% | +0.1% | −40.8% | $1.43B |
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.